H1N1: Governments Increase Orders for Glaxo's Vaccine

In a press release today, GlaxoSmithKline (GSK), says governments have increased orders for H1N1 vaccine: "governments around the world have so far ordered 440 million doses of its pandemic swine-flu vaccine Pandemrix as they brace for a possible resurgence of the illness".

Initial supplies of the drug maker's vaccine are scheduled to commence this week. A company spokeswoman declined to provide details on the delivery schedule but said shipments would be phased in to multiple destinations simultaneously.

We track H1N1 vaccine and related companies live on this site.



It sounds to em that these companies are desperate to get their stock prices up. There is so many of them racing to supply H1N1 and they are making so much noise about this "pandemic". These companies may actually be good shorting candidates.

P.R: "GSK confirmed that it had contracts in place to supply 291 million doses of the vaccine and had a variety of agreements in place with the US Government to supply pandemic products worth $250 million.
Since that date, 22 government orders have been agreed to supply a further 149 million doses of the vaccine. This now brings the total number of doses ordered for GSK’s pandemic vaccines to 440 million. Discussions continue with governments for further supplies.
First supplies of the vaccine will be shipped to governments during the week commencing 5th October. Shipments of the vaccine will be delivered in both the fourth quarter of 2009 and the first half of 2010.
The vaccine deliveries are contingent on a number of factors including government import/export regulations, regulatory approvals, approvals for outsourced packaging and filling as well as testing required by reference laboratories. "